Enterprise Value
18.06M
Cash
16.99M
Avg Qtr Burn
-6.617M
Short % of Float
0.34%
Insider Ownership
24.43%
Institutional Own.
30.27%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
INB-400 Details Glioblastoma, Cancer | Phase 2 Data readout | |
INB-200 Details Glioblastoma | Phase 1 Data readout | |
INB-100 Details Leukemia, Blood cancer, Cancer | Phase 1 Data readout |